Cryo-Cell International Azioni (AMEX: CCEL)

Ultime notizie per Cryo-Cell International (AMEX:CCEL) Azioni

Cryo-Cell International

CRYO-CELL INTL INC

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Press Releases

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

CCEL

Cryo-Cell International, Inc. Common Stock

Maxim Group

Comments

Cryo-Cell International

Notizie

Ultime notizie per Cryo-Cell International (AMEX:CCEL) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO